|
1
|
Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S,
Zhang Q, Shi X, Wang Q, Zhang L and Wang X: Structure of the
SARS-CoV-2 spike receptor-binding domain bound to the ACE2
receptor. Nature. 581:215–220. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Catanzaro M, Fagiani F, Racchi M, Corsini
E, Govoni S and Lanni C: Immune response in COVID-19: Addressing a
pharmacological challenge by targeting pathways triggered by
SARS-CoV-2. Signal Transduct Target Ther. 5(84)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,
Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk
factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: A retrospective cohort study. Lancet. 395:1054–1062.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Helms J, Kremer S, Merdji H, Clere-Jehl R,
Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana
M, et al: Neurologic Features in Severe SARS-CoV-2 Infection. N
Engl J Med. 382:2268–2270. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Richardson S, Hirsch JS, Narasimhan M,
Crawford JM, McGinn T and Davidson KW: The Northwell COVID-19
Research Consortium. Barnaby DP, Becker LB, Chelico JD, et al:
Presenting characteristics, comorbidities, and outcomes among 5700
patients hospitalized with COVID-19 in the New York City Area.
JAMA. 323:2052–2059. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Beghi E, Helbok R, Ozturk S, Karadas O,
Lisnic V, Grosu O, Kovács T, Dobronyi L, Bereczki D, Cotelli MS, et
al: Short- and long-term outcome and predictors in an international
cohort of patients with neuro-COVID-19. Eur J Neurol. 29:1663–1684.
2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Townsend MJ, Kyle TK and Stanford FC:
Commentary: COVID-19 and obesity: Exploring biologic
vulnerabilities, structural disparities, and weight stigma.
Metabolism. 110(154316)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gong MN, Bajwa EK, Thompson BT and
Christiani DC: Body mass index is associated with the development
of acute respiratory distress syndrome. Thorax. 65:44–50.
2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Gazzaz ZJ: Diabetes and COVID-19. Open
Life Sci. 16:297–302. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Barron E, Bakhai C, Kar P, Weaver A,
Bradley D, Ismail H, Knighton P, Holman N, Khunti K, Sattar N, et
al: Associations of type 1 and type 2 diabetes with
COVID-19-related mortality in England: A whole-population study.
Lancet Diabetes Endocrinol. 8:813–822. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lind L, Eriksson K and Grahn A: Chemokines
and matrix metalloproteinases in cerebrospinal fluid of patients
with central nervous system complications caused by
varicella-zoster virus. J Neuroinflammation. 16(42)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Davey A, McAuley DF and O'Kane CM: Matrix
metalloproteinases in acute lung injury: Mediators of injury and
drivers of repair. Eur Respir J. 38:959–970. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang X and Khalil RA: Matrix
metalloproteinases, vascular remodeling, and vascular disease. Adv
Pharmacol. 81:241–330. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Vafadari B, Salamian A and Kaczmarek L:
MMP-9 in translation: From molecule to brain physiology, pathology,
and therapy. J Neurochem. 139 (Suppl 2):S91–S114. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cheng Z, Limbu MH, Wang Z, Liu J, Liu L,
Zhang X, Chen P and Liu B: MMP-2 and 9 in chronic kidney disease.
Int J Mol Sci. 18(776)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tsarouhas K, Tsitsimpikou C, Apostolakis
S, Haliassos A, Tzardi M, Panagiotou M, Tsatsakis A and Spandidos
DA: Homocysteine and metalloprotease-3 and -9 in patients with
ascending aorta aneurysms. Thromb Res. 128:e95–e99. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tsarouhas K, Soufla G, Apostolakis S,
Zaravinos A, Panagiotou M, Khoury M, Hassoulas JA, Tsatsakis AM and
Spandidos DA: Transcriptional regulation of TIMPs in ascending
aorta aneurysms. Thromb Res. 126:399–405. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hazra S, Chaudhuri AG, Tiwary BK and
Chakrabarti N: Matrix metallopeptidase 9 as a host protein target
of chloroquine and melatonin for immunoregulation in COVID-19: A
network-based meta-analysis. Life Sci. 257(118096)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ben Moftah M and Eswayah A: Intricate
relationship between SARS-CoV-2-induced shedding and cytokine storm
generation: A signaling inflammatory pathway augmenting COVID-19.
Health Sci Rev (Oxf). 2(100011)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Charzewski L, Krzysko KA and Lesyng B:
Structural characterisation of inhibitory and non-inhibitory
MMP-9-TIMP-1 complexes and implications for regulatory mechanisms
of MMP-9. Sci Rep. 11(13376)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Martinez Mesa A, Cabrera Cesar E,
Martin-Montanez E, Sanchez Alvarez E, Lopez PM, Romero-Zerbo Y,
Garcia-Fernandez M and Velasco Garrido JL: Acute lung injury
biomarkers in the prediction of COVID-19 severity: Total thiol,
ferritin and lactate dehydrogenase. Antioxidants (Basel).
10(1221)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ramezani S, Ezzatifar F, Hojjatipour T,
Hemmatzadeh M, Shabgah AG, Navashenaq JG, Aslani S, Shomali N,
Arabi M, Babaie F, et al: Association of the matrix
metalloproteinases (MMPs) family gene polymorphisms and the risk of
coronavirus disease 2019 (COVID-19); implications of contribution
for development of neurological symptoms in the COVID-19 patients.
Mol Biol Rep. 50:173–183. 2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kassianidis G, Siampanos A, Poulakou G,
Adamis G, Rapti A, Milionis H, Dalekos GN, Petrakis V, Sympardi S,
Metallidis S, et al: Calprotectin and Imbalances between
Acute-Phase Mediators Are Associated with Critical Illness in
COVID-19. Int J Mol Sci. 23(4894)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Nasr El-Din A, Ata KAE, Abdel-Gawad AR and
Fahmy NF: Impact of high serum levels of MMP-7, MMP-9, TGF-β and
PDGF macrophage activation markers on severity of COVID-19 in
obese-diabetic patients. Infect Drug Resist. 14:4015–4025.
2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bonetto V, Pasetto L, Lisi I, Carbonara M,
Zangari R, Ferrari E, Punzi V, Luotti S, Bottino N, Biagianti B, et
al: Markers of blood-brain barrier disruption increase early and
persistently in COVID-19 patients with neurological manifestations.
Front Immunol. 13(1070379)2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gelzo M, Cacciapuoti S, Pinchera B, De
Rosa A, Cernera G, Scialò F, Comegna M, Mormile M, Fabbrocini G,
Parrella R, et al: Matrix metalloproteinases (MMP) 3 and 9 as
biomarkers of severity in COVID-19 patients. Sci Rep.
12(1212)2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Savic G, Stevanovic I, Mihajlovic D,
Jurisevic M, Gajovic N, Jovanovic I and Ninkovic M: MMP-9/BDNF
ratio predicts more severe COVID-19 outcomes. Int J Med Sci.
19:1903–1911. 2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lerum TV, Maltzahn NN, Aukrust P, Trøseid
M, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Haugli M,
Blomberg B, et al: Persistent pulmonary pathology after COVID-19 is
associated with high viral load, weak antibody response, and high
levels of matrix metalloproteinase-9. Sci Rep.
11(23205)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Iwasaki-Hozumi H, Maeda Y, Niki T,
Chagan-Yasutan H, Bai G, Matsuba T, Furushima D, Ashino Y and
Hattori T: Plasma N-Cleaved Galectin-9 is a surrogate marker for
determining the severity of COVID-19 and monitoring the therapeutic
effects of tocilizumab. Int J Mol Sci. 24(3591)2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Moin ASM, Sathyapalan T, Atkin SL and
Butler AE: Pro-fibrotic M2 macrophage markers may increase the risk
for COVID19 in type 2 diabetes with obesity. Metabolism.
112(154374)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Springall R, Gonzalez-Flores J,
Garcia-Avila C, Juárez-Vicuña Y, Hernández-Diazcouder A,
Márquez-Velasco R, Cásares-Alvarado S, Sánchez-Muñoz F,
Basilio-Gálvez E, Castillo-Salazar M, et al: Elevated levels of
soluble CD147 are associated with hyperinflammation and disease
severity in COVID-19: A proof-of-concept clinical study. Arch
Immunol Ther Exp (Warsz). 70(18)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Petito E, Falcinelli E, Paliani U, Cesari
E, Vaudo G, Sebastiano M, Cerotto V, Guglielmini G, Gori F,
Malvestiti M, et al: Association of neutrophil activation, more
than platelet activation, with thrombotic complications in
coronavirus disease 2019. J Infect Dis. 223:933–944.
2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mohammadhosayni M, Sadat Mohammadi F,
Ezzatifar F, Mahdavi Gorabi A, Khosrojerdi A, Aslani S, Hemmatzadeh
M, Yazdani S, Arabi M, Marofi F, et al: Matrix metalloproteinases
are involved in the development of neurological complications in
patients with Coronavirus disease 2019. Int Immunopharmacol.
100(108076)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liberati A, Altman DG, Tetzlaff J, Mulrow
C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J
and Moher D: The PRISMA statement for reporting systematic reviews
and meta-analyses of studies that evaluate healthcare
interventions: Explanation and elaboration. BMJ.
339(b2700)2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wells G, Shea B, O'Connell D, Robertson J,
Peterson J, Welch V, Losos M and Tugwell P: The Newcastle–Ottawa
Scale (NOS) for Assessing the Quality of Non-Randomized Studies in
Meta-Analysis. Enviromental Sci, 2014.
|
|
36
|
Sharma A, Ahmad Farouk I and Lal SK:
COVID-19: A review on the novel coronavirus disease evolution,
transmission, detection, control and prevention. Viruses.
13(202)2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Huang H: Matrix metalloproteinase-9
(MMP-9) as a cancer biomarker and MMP-9 Biosensors: Recent
advances. Sensors (Basel). 18(3249)2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Sato A, Nishida C, Sato-Kusubata K,
Ishihara M, Tashiro Y, Gritli I, Shimazu H, Munakata S, Yagita H,
Okumura K, et al: Inhibition of plasmin attenuates murine acute
graft-versus-host disease mortality by suppressing the matrix
metalloproteinase-9-dependent inflammatory cytokine storm and
effector cell trafficking. Leukemia. 29:145–156. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hsu AT, Barrett CD, DeBusk GM, Ellson CD,
Gautam S, Talmor DS, Gallagher DC and Yaffe MB: Kinetics and role
of plasma matrix metalloproteinase-9 expression in acute lung
injury and the acute respiratory distress Syndrome. Shock.
44:128–136. 2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Tang Y, Liu J, Zhang D, Xu Z, Ji J and Wen
C: Cytokine Storm in COVID-19: The current evidence and treatment
strategies. Front Immunol. 11(1708)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Duda I, Krzych L, Jedrzejowska-Szypulka H
and Lewin-Kowalik J: Plasma matrix metalloproteinase-9 and tissue
inhibitor of matrix metalloproteinase-1 as prognostic biomarkers in
critically Ill Patients. Open Med (Wars). 15:50–56. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Nemec HM, Ferenczy A, Christie BD III,
Ashley DW and Montgomery A: Correlation of D-dimer and Outcomes in
COVID-19 Patients. Am Surg. 88:2115–2118. 2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Khan E: Heart failure and COVID-19:
Synergism of two inflammatory conditions? Br J Community Nurs.
26:18–25. 2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Marchesi C, Dentali F, Nicolini E, Maresca
AM, Tayebjee MH, Franz M, Guasti L, Venco A, Schiffrin EL, Lip GY
and Grandi AM: Plasma levels of matrix metalloproteinases and their
inhibitors in hypertension: A systematic review and meta-analysis.
J Hypertens. 30:3–16. 2012.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Mondal S, Adhikari N, Banerjee S, Amin SA
and Jha T: Matrix metalloproteinase-9 (MMP-9) and its inhibitors in
cancer: A minireview. Eur J Med Chem. 194(112260)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Carmona-Rivera C, Zhao W, Yalavarthi S and
Kaplan MJ: Neutrophil extracellular traps induce endothelial
dysfunction in systemic lupus erythematosus through the activation
of matrix metalloproteinase-2. Ann Rheum Dis. 74:1417–1424.
2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Desforges M, Le Coupanec A, Stodola JK,
Meessen-Pinard M and Talbot PJ: Human coronaviruses: Viral and
cellular factors involved in neuroinvasiveness and
neuropathogenesis. Virus Res. 194:145–158. 2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Unal R, Yao-Borengasser A, Varma V,
Rasouli N, Labbate C, Kern PA and Ranganathan G: Matrix
metalloproteinase-9 is increased in obese subjects and decreases in
response to pioglitazone. J Clin Endocrinol Metab. 95:2993–3001.
2010.PubMed/NCBI View Article : Google Scholar
|
